No Data
Sunshine Biopharma Expands Its Product Line to 69 Generic Prescription Drugs by Launching Olanzapine and Olanzapine ODT
Sunshine Biopharma Announces the Appointment of New Chief Commercial Officer
Sunshine Biopharma Files For Offering Of Mixed Shelf Of Up To $100M
Express News | Sunshine Biopharma Announces Development Of An Orally Active Protease Inhibitor With Dose-Dependent Antiviral Activity In Mice With SARS-CoV-2)
Express News | Aegis Capital Reiterates Buy on Sunshine Biopharma, Maintains $15 Price Target
Sunshine Biopharma Analyst Ratings
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
